Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8539 ...
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8539 ...
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...
5d
The global Clinical Trial Services Market, valued at US$60.76 billion in 2024, is forecasted to grow at a robust CAGR of 8.9% ...
Since the FDA’s groundbreaking approval of Zarxio in 2015, the US biosimilars market has surged to 67 approvals across 18 ...
Key Players: Major companies operating in the molecular spectroscopy market are Thermo Fisher Scientific, Inc, Merck KGaA, PerkinElmer Inc., Agilent Technologies, Inc, Bruker, Horiba, Ltd, Shimadzu ...
It has been 10 years since the first biosimilar was approved by the FDA. The grades on how the market for biosimilars has ...
11d
Sandoz is one of the largest biosimilars players in the world and we believe it is well-positioned to benefit from the fast pace of growth the market is expected to enjoy over the next decade. Sandoz ...
Pharmacy benefit managers take considerably different approaches to managing patient access to biosimilars, or cheaper ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASEFY 2024 net sales[1] of USD 10.4 billion, up by 9%[2] in ...
The rise in Biocon share price came after the company announced that its wholly-owned subsidiary, Biocon Pharma, has received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback